NWPF

News ArchivesRead News

Eye implants offer Parkinson’s hope

Thursday December 15, 2005

Wai Lang Chu

12/13/05(Archives of Neurology) - A new therapy for Parkinson’s disease involving brain implants has been developed by US scientists, who believe this new treatment is a viable alternative to drugs currently used to treat this chronic irreversible brain condition.

Levodopa is currently the most common drug treatment for the brain condition but the pills can leave people susceptible to involuntary movements such as twitches. It is normally prescribed a few years after diagnosis as the symptoms get worse.

In addition, disease progression and long-term oral treatment with levodopa may lead to the development of motor fluctuations and dyskinesias

This new approach involved taking levadopa producing eye cells taken from a dead donor and implanting the directly into the brains of six Parkinsons patients. The researchers reported no serious side effects.

Eye cells that form retinal pigment epithelial tissue produce levodopa and can be isolated from human eye tissue and implanted in the brain. Research on animals has shown that the cell implants can help treat the symptoms safely.

The retina cells were cultivated and implanted in the brains of six patients with advanced Parkinson’s, said researcher Natividad Stover of the University of Alabama.

One year later, the patients scored 48 per cent higher on tests of movement and coordination, and the improvement was sustained after two years, Stover wrote in the report.

"The implants were well tolerated," the report said. "Improvement was also observed in activities of daily living (and) quality of life."

The study is additional proof that the technique could work on humans and paves the way for a larger, more thorough study.

Indeed, Stover added that a randomised, double-blind, placebo-controlled study was now in the pipeline to test the treatment further.

For most patients, the levodopa pills lose their effectiveness over five years or less, and larger and larger doses are needed to keep at bay the involuntary movements and shaking symptomatic of the disease.

Some scientists have viewed implanting foetal stem cells into the brains of Parkinson’s patients as a promising avenue to restoring dopamine production. But preliminary human trials were disappointing, and animal experiments have yielded mixed results.

Other treatments showing promise include deep brain stimulation with implanted electrodes, drugs that promote brain cell growth, and gene therapy

Recent News

May 20 - Book Review: Aging in the Key of Humor
May 19 - Press Release: The Michael J. Fox Foundation for Parkinson's Research Joins Multinational Critical Path for Parkinson's Consortium
May 19 - Congress reaches deal to overhaul chemical regulation
May 16 - Lifestyle: Why Parkinson's disease won't stop me rowing across the Pacific
May 16 - Many biomarkers for PD fail to inform on progression
May 10 - Parkinson's Cell Transplant Shows Good Reinnervation at 24 Years
May 7 - Growing art installation gathers stories of living with Parkinson's
May 5 - New technique can provide better cell transplants against Parkinson's disease
May 2 - What's Good For The Heart Is Good For The Brain
Apr 29 - Press Release: FDA approves first drug to treat hallucinations and delusions associated with Parkinson’s disease
Apr 28 - Dopamine-making neurons can be chemically controlled in animal model of Parkinson's
Apr 25 - Lifestyle: Dating with Disease
Apr 25 - Scientific breakthrough in fight against Parkinson's and Alzheimer's
Apr 20 - Breakthrough Parkinson's disease blood test
Apr 15 - Living with Parkinson's
Apr 12 - Tissue biomarker for dementia with Lewy bodies and Parkinson’s disease
Apr 11 - Yoga for Every Body: Experts say yoga can ease pain and improve mobility for people with neurologic conditions
Apr 9 - Commonly prescribed Parkinson's drugs up risk of compulsive gambling, shopping, binge eating, hypersexuality
Apr 7 - Pfizer and IBM Launch Innovative Research Project to Transform Parkinson's Disease Care
Apr 7 - Parkinson's Drug Highly Effective for Resistant Depression